K Kotseva

Summary

Affiliation: Imperial College
Country: UK

Publications

  1. doi request reprint EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries
    Kornelia Kotseva
    Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK
    Eur J Cardiovasc Prev Rehabil 17:530-40. 2010
  2. ncbi request reprint Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional su
    Kornelia Kotseva
    European Society of Cardiology, Sophia Antipolis, France International Centre for Circulatory Health, Imperial College London, UK
    Eur J Prev Cardiol . 2016
  3. doi request reprint Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013
    Kornelia Kotseva
    International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, United Kingdom Electronic address
    Glob Heart . 2016
  4. doi request reprint Implementation of Cardiovascular Disease Prevention Guidelines in Clinical Practice-Can We Do Better?
    Kornelia Kotseva
    Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK
    Curr Treat Options Cardiovasc Med 17:58. 2015
  5. doi request reprint EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries
    Kornelia Kotseva
    The European Society of Cardiology, Sophia Antipolis Cedex, France International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, UK
    Eur J Prev Cardiol 23:636-48. 2016
  6. doi request reprint ASPIRE-2-PREVENT: a survey of lifestyle, risk factor management and cardioprotective medication in patients with coronary heart disease and people at high risk of developing cardiovascular disease in the UK
    Kornelia Kotseva
    Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, St Mary s Campus, International Centre for Circulatory Health, Lower 3rd Floor, 59 61 North Wharf Road, London W2 1LA, UK
    Heart 98:865-71. 2012
  7. ncbi request reprint Treatment potential for cholesterol management in patients with coronary heart disease in 15 European countries: findings from the EUROASPIRE II survey
    K Kotseva
    Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, Charing Cross Hospital 5th Floor, Laboratory Block, Fulham Palace Road, London W6 8RF, United Kingdom
    Atherosclerosis 197:710-7. 2008
  8. ncbi request reprint Global preventive policies. Strategies at European and worldwide level
    Kornelia Kotseva
    Cardiovascular Medicine, National Heart and Lung Institute, Imperial College, London, UK
    Rev Esp Cardiol 61:960-70. 2008
  9. doi request reprint Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries
    Kornelia Kotseva
    Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK
    Lancet 373:929-40. 2009
  10. doi request reprint EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries
    Kornelia Kotseva
    Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK
    Eur J Cardiovasc Prev Rehabil 16:121-37. 2009

Detail Information

Publications14

  1. doi request reprint EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries
    Kornelia Kotseva
    Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK
    Eur J Cardiovasc Prev Rehabil 17:530-40. 2010
    ..To determine whether the 2003 Joint European Societies' guidelines on cardiovascular disease prevention in people at high cardiovascular risk have been followed in general practice...
  2. ncbi request reprint Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional su
    Kornelia Kotseva
    European Society of Cardiology, Sophia Antipolis, France International Centre for Circulatory Health, Imperial College London, UK
    Eur J Prev Cardiol . 2016
    ..The main objective was to determine whether the 2012 Joint European Societies' guidelines on cardiovascular disease (CVD) prevention in people at high CVD risk have been followed in clinical practice...
  3. doi request reprint Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013
    Kornelia Kotseva
    International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, United Kingdom Electronic address
    Glob Heart . 2016
    ....
  4. doi request reprint Implementation of Cardiovascular Disease Prevention Guidelines in Clinical Practice-Can We Do Better?
    Kornelia Kotseva
    Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK
    Curr Treat Options Cardiovasc Med 17:58. 2015
    ..Coronary intervention should always be followed by prevention...
  5. doi request reprint EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries
    Kornelia Kotseva
    The European Society of Cardiology, Sophia Antipolis Cedex, France International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, UK
    Eur J Prev Cardiol 23:636-48. 2016
    ....
  6. doi request reprint ASPIRE-2-PREVENT: a survey of lifestyle, risk factor management and cardioprotective medication in patients with coronary heart disease and people at high risk of developing cardiovascular disease in the UK
    Kornelia Kotseva
    Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, St Mary s Campus, International Centre for Circulatory Health, Lower 3rd Floor, 59 61 North Wharf Road, London W2 1LA, UK
    Heart 98:865-71. 2012
    ....
  7. ncbi request reprint Treatment potential for cholesterol management in patients with coronary heart disease in 15 European countries: findings from the EUROASPIRE II survey
    K Kotseva
    Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, Charing Cross Hospital 5th Floor, Laboratory Block, Fulham Palace Road, London W6 8RF, United Kingdom
    Atherosclerosis 197:710-7. 2008
    ..This has prompted international guidelines on prevention of CHD to include recommendations on dietary and pharmacological treatment of hyperlipidaemia with set goals on total- and LDL-cholesterol...
  8. ncbi request reprint Global preventive policies. Strategies at European and worldwide level
    Kornelia Kotseva
    Cardiovascular Medicine, National Heart and Lung Institute, Imperial College, London, UK
    Rev Esp Cardiol 61:960-70. 2008
    ..The guidelines provide guidance to policy-makers and health care workers on how to target high risk people in different resource settings, using evidence-based and cost-effective preventive approaches...
  9. doi request reprint Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries
    Kornelia Kotseva
    Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK
    Lancet 373:929-40. 2009
    ....
  10. doi request reprint EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries
    Kornelia Kotseva
    Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, London, UK
    Eur J Cardiovasc Prev Rehabil 16:121-37. 2009
    ....
  11. doi request reprint Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlle
    D A Wood
    Department of Cardiovascular Medicine, National Heart and Lung Institute at Charing Cross Campus, Imperial College, London, UK
    Lancet 371:1999-2012. 2008
    ..Our aim was to investigate whether a nurse-coordinated multidisciplinary, family-based preventive cardiology programme could improve standards of preventive care in routine clinical practice...
  12. ncbi request reprint [Cardiovascular risk reduction: impact of an international project]
    B Colle
    Direzione Sanitaria A S S n 3 Alto Friuli
    Ann Ig 20:43-8. 2008
    ..The experimented intervention model based on a multidisciplinary approach and nurses leaded showed a good one year impact in reducing cardiovascular risk factors in high risk people. This model should be further tested in local contexts...
  13. ncbi request reprint Screening of family members of patients with premature coronary heart disease; results from the EUROASPIRE II family survey
    J De Sutter
    Department of Public Health, University Hospital, De Pintelaan 185, 9000, Gent, Belgium
    Eur Heart J 24:249-57. 2003
    ....
  14. ncbi request reprint Cardiovascular effects in viscose rayon workers exposed to carbon disulfide
    K Kotseva
    Department of Public Health, Ghent University, Belgium
    Int J Occup Environ Health 7:7-13. 2001
    ..The findings suggest that the coronary risk is increased in workers previously exposed to high CS2 concentrations but not in those exposed to CS2 levels below the current TLV...